Alloy Therapeutics and Wheeler Bio Announce Preferred Service Offering for Alloy Partners to Accelerate the Translation from Discovery to CMC
Wheeler Bio
PR-M11-23-01Nov 08, 2023
Wheeler Bio Announces Grand Opening of Biomanufacturing Facility
Wheeler Bio
PR-M10-23-01Oct 05, 2023
New Biomanufacturing Facility
Samsung Biologics Announces Construction of Plant 5 to Commence Bio Campus II Capacity Expansion
Samsung Biologics
PR-M03-23-05Mar 17, 2023
Biomanufacturing Facility
OmniaBio, CCRM and Stakeholders Celebrate Commencement of Construction of Hamilton Biomanufacturing Facility
OmniaBio
PR-M10-22-05Oct 06, 2022
Pharma 4.0
Applying an Advanced Pharma 4.0 Perspective to Design the Facility of the Future
Yuk Chun Chiu, M.S.E.; Dawn Wofford; Patricia Robbins; Yvonne Duckworth; Steve Attig
Wheeler Bio
PAO-06-022-CL-11Sep 08, 2022
New Biodefense Facility
Scorpion Biological Services Announces New Kansas Commercial Biomanufacturing Facility
Scorpius BioManufacturing
PR-M04-22-12Apr 26, 2022
New Biodefense Facility
Heat Biologics’ Scorpion Subsidiary Announces Planned Development of New Kansas Commercial/Biodefense Biomanufacturing Facility
Heat Biologics
PR-M04-22-10Apr 18, 2022
Expansion
New Facilities Help AGC Biologics Discover What's Possible
Patricio E. Massera
AGC Biologics
PAO-03-22-R250-16Mar 19, 2022
Recombinant Proteins
Meeting the Renewed Demand for Microbial Protein Production
Grifols Recombinant Protein CDMO
PAO-01-22-R250-07Jan 28, 2022
Evotec Accelerates Access to Biologic Therapeutics with Initiation of Manufacturing Facility in Toulouse
Evotec
PR-M04-21-020Apr 20, 2021
Biomanufacturing Facility
LakePharma Announces its cGMP MicroBiomanufacturing Center is Now Operational
LakePharma
PR-M12-18-NI-073Dec 21, 2018
Investment
WuXi Biologics to Invest €325 Million to Build Largest Biomanufacturing Facility Using Single-Use Bioreactors in Ireland
WuXi Biologics
PR-M05-18-NI-011 May 03, 2018